Kunihito Gotoh
Papers
2
Total Citations
12
H-Index
2
About
Dr. Kunihito Gotoh is a leading surgical oncologist whose research focuses on advancing minimally invasive and targeted therapies for gastric and gastroesophageal junction cancers. His major contributions lie in comparing robotic and laparoscopic gastrectomy outcomes, where his 2025 study on perioperative performance and three-year survival—cited 10 times—provides critical evidence for optimizing surgical approaches. Dr. Gotoh has also pioneered conversion surgery following zolbetuximab-based chemotherapy for CLDN18.2-positive tumors, a novel targeted strategy that offers new hope for patients with advanced disease. His work, though recent, demonstrates significant impact by bridging precision oncology with surgical innovation. Notably, his investigations into CLDN18.2-directed therapies highlight his role at the forefront of biomarker-driven treatment paradigms. With a growing citation record, Dr. Gotoh’s research is shaping future standards in gastric cancer surgery and multimodal care, making him a key figure in the field.
Research Focus
Key Achievements
Top Papers
- 1
- 2